Aurora Cannabis (CSE:ACB) provided a number of operational updates on Friday, noting that it had surpassed 1,000 registered patients in three months.
As quoted in the press release:
Aurora’s patient registration has been faster than anticipated, surpassing 1,000 active registered patients less than three months after the Company’s first sale of product on January 5, 2016. This is believed to be the shortest time required to meet this milestone of any Licensed Producer in Canada. Of the approximately 15 strains currently in the Company’s product line, the top seller over the month of March, 2016 was Aurora’s “Temple” strain, which contains 24% cannabidiol (CBD). This is the highest-CBD medical cannabis available in Canada today.